BRIEF published on 11/08/2024 at 11:03, 13 days 3 hours ago Voyageurs du Monde publishes its voting rights data as of October 31, 2024 Share Capital Voting Rights Financial Regulations World Travelers Shares Outstanding
BRIEF published on 10/09/2024 at 18:05, 1 month 11 days ago Voyageurs du Monde posts stable performance in the first half EBITDA Turnover Growth Outlook World Travelers Tailor-made Trips
PRESS RELEASE published on 10/09/2024 at 18:01, 1 month 11 days ago Voyageurs du Monde: Solid first half performance Voyageurs du Monde group reports solid first half performance in 2024 with sales up 10.6% and EBITDA growth of 13.8%. Net income slightly down due to exceptional loss. Group outlook positive for the rest of the year EBITDA Financial Performance Sales Growth Outlook Voyageurs Du Monde
PRESS RELEASE published on 10/09/2024 at 18:00, 1 month 11 days ago Voyageurs du Monde: Solid first half performance Voyageurs du Monde reports a solid first half performance with sales up 10.6% at €289.0m. EBITDA increased by 13.8% to €9.6 million. The group shows promising growth outlook for 2024 EBITDA Sales Growth Outlook Solid Performance Voyageurs Du Monde
BRIEF published on 10/03/2024 at 13:05, 1 month 18 days ago Details of Voyageurs du Monde shares and voting rights Voting Rights Actions Paris World Travelers Trade
BRIEF published on 07/25/2024 at 15:27, 3 months 26 days ago Voyageurs du Monde: Information relating to voting rights and shares Share Capital Voting Rights Actions AMF World Travelers
BRIEF published on 07/25/2024 at 15:27, 3 months 26 days ago Voyageurs du Monde: Information relating to the total number of voting rights and shares Capital Actions World Travelers Right To Vote Regulatory
BRIEF published on 07/25/2024 at 12:52, 3 months 27 days ago VOYAGEURS DU MONDE: Information on shares and voting rights as of July 23, 2024 Share Capital Voting Rights Actions Financial Markets World Travelers
BRIEF published on 07/17/2024 at 18:05, 4 months 3 days ago Voyageurs du Monde: Results of the public share buyback offer Share Buyback AMF Finance Public Offer World Travelers
BRIEF published on 07/02/2024 at 16:04, 4 months 18 days ago Total number of voting rights of Voyageurs du Monde as of June 30, 2024 Voting Rights AMF Outstanding Shares World Travelers
Published on 11/21/2024 at 13:30, 35 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 35 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 5 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 30 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 50 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 7 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 45 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 20 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
